Opportunity to Partner OncoSec: a Novel Immunotherapy Company10 December 2018 - New York and London - The Sage Group is pleased to announce that it is working with OncoSec, an American corporation,...
ASIT biotech initiates the search for a strategic commercial partner for the future marketing of gp-• The Sage Group, an internationally recognized consulting group, has been appointed to identify a commercial partner with a special...
Moberg's BUPIZENGE™ - Sage Group Offers An Opportunity for Leadership in Pain Relief for Oral MuStockholm, Sweden, 8 September 2018 – Moberg has appointed The Sage Group to lead the BUPIZENGE™ partnering program. Moberg Pharma is a...
Sage Group Represents Solvotrin to License Their Novel ActiveIronTM Product PortfolioSage Group is working with Solvotrin Therapeutics (“Solvotrin”), based in Cork, Ireland. Solvotrin is a drug development company focused...